Aug 19 – Medtronic (MDT.N) opens new tab will add two new directors and form new committees, after Elliott Investment Management became one of its largest shareholders, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.
Medtronic PLC is an American-Irish medical device company with its operational headquarters in Minneapolis, Minnesota, and its legal and executive headquarters in Ireland. It is one of the world’s largest medical technology companies, operating in over 150 countries and employing more than 90,000 people.
The company was founded in 1949 as a medical equipment repair shop. Medtronic is known for developing and manufacturing various healthcare technologies and therapies, including the world’s first battery-operated pacemaker, the implantable cardioverter defibrillator, and other devices for a wide range of medical conditions.
Medtronic appoints Dr Joon Lee to board
Medtronic plc announced that its Board of Directors appointed Dr Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board.
“We are thrilled to welcome Dr Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic’s Board of Directors,” said Geoff Martha, chairman and chief executive officer. “Dr Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with decades of broad leadership across healthcare. He is passionate about leveraging data and technology to improve the patient and provider experience-insights that will help us further our Mission to alleviate pain, restore health, and extend life for patients around the world.”
In his current role as CEO of Emory Healthcare, Inc., Dr Lee oversees the most comprehensive academic health system in Georgia, with $7.7B in yearly revenue, 12 hospitals, and more than 29,000 employees.
Dr Lee’s distinguished career spans more than 25 years at the University of Pittsburgh Medical Center (UPMC), where he held pivotal roles, including Executive Vice President and President of Physician Services. There, his scope included physician services, patient experience, patient access and financial oversight of physician services. He also served as Vice Dean of Clinical Affairs at the University of Pittsburgh School of Medicine.
Additionally, Dr Lee served as Chief of the Division of Cardiology and was the founding executive director of the UPMC Heart and Vascular Institute. From 2019 to 2021, Dr Lee was the Chief Medical Officer of UPMC Insurance Services, a $13 billion full-service health insurance division of UPMC.
Dr Lee is certified in cardiovascular disease by the American Board of Internal Medicine. He is a fellow in the American College of Cardiology and Society for Coronary Angiography and Interventions. He completed a medical internship and residency, as well as two cardiology fellowships in cardiology and interventional cardiology, at Massachusetts General Hospital in Boston. In addition, he was an instructor at Harvard Medical School. He is a graduate of Dartmouth College (BA) and Duke University (MD).